4.7 Article

An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity

Journal

CELL HOST & MICROBE
Volume 25, Issue 4, Pages 578-+

Publisher

CELL PRESS
DOI: 10.1016/j.chom.2019.03.002

Keywords

-

Funding

  1. CIHR foundation [352417]
  2. NIH R01 [AI129769, AI122953, AI124982]
  3. NIAID R01 [AI116274]
  4. Gilead Sciences Research Scholars Program in HIV
  5. Campbell Foundation for AIDS Research
  6. Canada Research Chair on Retroviral Entry [RCHS0235]
  7. King Abdullah scholarship for higher education from the Saudi Government
  8. Mathilde Krim Fellowships in Basic Biomedical Research from AmfAR
  9. FRSQ postdoctoral fellowship award
  10. FRQS Senior Research Scholar Award
  11. STEM-M Stimulus Fund (University of Melbourne)
  12. National Cancer Institute, NIH [HHSN261200800001E]
  13. NIH [1K22AI116262]
  14. NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID) [AI100663]
  15. [R01-GM56550]

Ask authors/readers for more resources

The HIV-1 envelope glycoprotein (Env) (gp120-gp41)(3) is the target for neutralizing antibodies and antibody-dependent cellular cytotoxicity (ADCC). HIV-1 Env is flexible, sampling different conformational states. Before engaging CD4, Env adopts a closed conformation (State 1) that is largely antibody resistant. CD4 binding induces an intermediate state (State 2), followed by an open conformation (State 3) that is susceptible to engagement by antibodies that recognize otherwise occluded epitopes. We investigate conformational changes in Env that induce ADCC in the presence of a smallmolecule CD4-mimetic compound (CD4mc). We uncover an asymmetric Env conformation (State 2A) recognized by antibodies targeting the conserved gp120 inner domain and mediating ADCC. Sera from HIV+ individuals contain these antibodies, which can stabilize Env State 2A in combination with CD4mc. Additionally, triggering State 2A on HIV-infected primary CD4(+) T cells exposes epitopes that induce ADCC. Strategies that induce this Env conformation may represent approaches to fight HIV-1 infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available